OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prognostic and pharmacologic value of cystatin SN for chronic rhinosinusitis with nasal polyps
Di Wu, Bing Yan, Yang Wang, et al.
Journal of Allergy and Clinical Immunology (2021) Vol. 148, Iss. 2, pp. 450-460
Closed Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Endotypes of chronic rhinosinusitis: Relationships to disease phenotypes, pathogenesis, clinical findings, and treatment approaches
Atsushi Kato, Anju T. Peters, Whitney W. Stevens, et al.
Allergy (2021) Vol. 77, Iss. 3, pp. 812-826
Open Access | Times Cited: 166

Prognostic factors for polyp recurrence in chronic rhinosinusitis with nasal polyps
Junqin Bai, Julia Huang, Caroline P.E. Price, et al.
Journal of Allergy and Clinical Immunology (2022) Vol. 150, Iss. 2, pp. 352-361.e7
Open Access | Times Cited: 73

Current insight into treatment of chronic rhinosinusitis: Phenotypes, endotypes, and implications for targeted therapeutics
Nikita Chapurin, Jeffanie Wu, Alex B. Labby, et al.
Journal of Allergy and Clinical Immunology (2022) Vol. 150, Iss. 1, pp. 22-32
Open Access | Times Cited: 51

Highlights in the advances of chronic rhinosinusitis
Xinni Xu, Sietze Reitsma, De Yun Wang, et al.
Allergy (2021) Vol. 76, Iss. 11, pp. 3349-3358
Closed Access | Times Cited: 44

Cystatin SN is a potent upstream initiator of epithelial-derived type 2 inflammation in chronic rhinosinusitis
Angela L. Nocera, Sarina K. Mueller, Alan D. Workman, et al.
Journal of Allergy and Clinical Immunology (2022) Vol. 150, Iss. 4, pp. 872-881
Open Access | Times Cited: 25

Sinonasal Biomarkers Defining Type 2-High and Type 2-Low Inflammation in Chronic Rhinosinusitis with Nasal Polyps
Eugenio De Corso, Silvia Baroni, Stefano Settimi, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 8, pp. 1251-1251
Open Access | Times Cited: 20

Epithelium‐derived cystatin SN inhibits house dust mite protease activity in allergic asthma
Lei Yao, Xijing Yuan, Heng Fu, et al.
Allergy (2023) Vol. 78, Iss. 6, pp. 1507-1523
Closed Access | Times Cited: 11

SerpinB3/B4 Abates Epithelial Cell-Derived CXCL8/IL-8 Expression in Chronic Rhinosinusitis with Nasal Polyps
Xiangting Bu, Ming Wang, Jing Yuan, et al.
Journal of Immunology Research (2024) Vol. 2024, pp. 1-13
Open Access | Times Cited: 4

Treatment Strategy of Uncontrolled Chronic Rhinosinusitis with Nasal Polyps: A Review of Recent Evidence
Sung‐Dong Kim, Kyu-Sup Cho
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 5015-5015
Open Access | Times Cited: 9

Periostin as a biomarker in chronic rhinosinusitis: A contemporary systematic review
Gerasimos Danielides, Spyridon Lygeros, Menelaos Kanakis, et al.
International Forum of Allergy & Rhinology (2022) Vol. 12, Iss. 12, pp. 1535-1550
Closed Access | Times Cited: 14

Prognostic factors for post-operative outcomes in chronic rhinosinusitis with nasal polyps: a systematic review
Shiru Cai, Hongfei Lou, Luo Zhang
Expert Review of Clinical Immunology (2023) Vol. 19, Iss. 8, pp. 867-881
Closed Access | Times Cited: 8

Cystatin SN in type 2 inflammatory airway diseases
Bing Yan, Yimin Ren, Chang Liu, et al.
Journal of Allergy and Clinical Immunology (2023) Vol. 151, Iss. 5, pp. 1191-1203.e3
Closed Access | Times Cited: 7

Precision medicine in chronic rhinosinusitis – using endotype and endotype-driven therapeutic options
Yutong Sima, Yan Zhao, Xiangdong Wang, et al.
Expert Review of Clinical Immunology (2023) Vol. 19, Iss. 8, pp. 949-958
Closed Access | Times Cited: 7

Advances in chronic rhinosinusitis in 2020 and 2021
Zhaofeng Xu, Yanran Huang, Tim Delemarre, et al.
Journal of Allergy and Clinical Immunology (2021) Vol. 149, Iss. 3, pp. 854-866
Open Access | Times Cited: 17

Immunological Aspects of Chronic Rhinosinusitis
Katarzyna Czerwaty, Katarzyna Piszczatowska, Jacek Brzost, et al.
Diagnostics (2022) Vol. 12, Iss. 10, pp. 2361-2361
Open Access | Times Cited: 11

A review of current biomarkers in chronic rhinosinusitis with or without nasal polyps
Tsuguhisa Nakayama, Shinichi Haruna
Expert Review of Clinical Immunology (2023) Vol. 19, Iss. 8, pp. 883-892
Closed Access | Times Cited: 6

Thymic Stromal Lymphopoietin (TSLP): Evidence in Respiratory Epithelial-driven Diseases Including Chronic Rhinosinusitis with Nasal Polyps
Eugenio De Corso, Peter W. Hellings, Wytske J. Fokkens, et al.
Current Allergy and Asthma Reports (2024) Vol. 25, Iss. 1
Closed Access | Times Cited: 2

Cystatin SN promotes epithelial-mesenchymal transition and serves as a prognostic biomarker in lung adenocarcinoma
Jian Yang, Gaomeng Luo, Chang Li, et al.
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 9

Endotyping Difficult-to-Treat Chronic Rhinosinusitis with Nasal Polyps by Structured Histopathology
Yueming Cui, Kanghua Wang, Jianbo Shi, et al.
International Archives of Allergy and Immunology (2023) Vol. 184, Iss. 10, pp. 1036-1046
Open Access | Times Cited: 5

Type 2 Cystatins and Their Roles in the Regulation of Human Immune Response and Cancer Progression
Zijun Zhang, Fenghuang Zhan
Cancers (2023) Vol. 15, Iss. 22, pp. 5363-5363
Open Access | Times Cited: 5

IL-13 and IL-13–induced periostin levels are specifically decreased in patients following endoscopic sinus surgery for chronic rhinosinusitis
Regan Harmon, Alexander L. Schneider, Junqin Bai, et al.
Journal of Allergy and Clinical Immunology (2023) Vol. 153, Iss. 5, pp. 1292-1305
Closed Access | Times Cited: 5

Factors for predicting the outcome of surgery for non-eosinophilic chronic rhinosinusitis with nasal polyps
Zhengqi Li, Tong Lu, Sun Lin, et al.
Annals of Allergy Asthma & Immunology (2024) Vol. 133, Iss. 5, pp. 559-567.e3
Closed Access | Times Cited: 1

Short‐term postoperative efficacy of steroid‐eluting stents for eosinophilic chronic rhinosinusitis with nasal polyps: A randomized clinical trial
Chengshuo Wang, Longgang Yu, Xiaohan Chu, et al.
International Forum of Allergy & Rhinology (2022) Vol. 13, Iss. 5, pp. 899-909
Closed Access | Times Cited: 7

Clinical and biological markers in disease and biologics to treat chronic rhinosinusitis
Cuilian Guo, Chongshu Wang, Zheng Liu
Current Opinion in Allergy and Clinical Immunology (2021) Vol. 22, Iss. 1, pp. 16-23
Closed Access | Times Cited: 9

Page 1 - Next Page

Scroll to top